microdosing.glp 1 Microdosing Semaglutide: Does It Work for Weight Loss? Microdosing GLP-1 Medications | Achieve

doi: 10.3390/nu14173567 159 SinghRBNabavizadehFFedackoJPellaDVanovaNJakabcinPet al

[4] Emerging research suggests that injectable peptides such as body protection compound 157 (BPC-157) are being explored for regenerative medicine applications, including tissue repair, recovery from musculoskeletal injuries, and potential enhancement of endurance and metabolism

This mirrors management strategies used in other scenarios with significant anticipated glycemic change, such as pregnancy, intensive insulin therapy or bariatric surgery

In patients with type 2 diabetes receiving insulin, GLP-1 RA initiation may require insulin dose reduction to minimize hypoglycemia risk